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1. Introduction 
Human antibodies against the Rh blood group 
antigens do not in general activate the complement 
system. Rare reports of activation are restricted to 
either anti-D of certain sera bound to enzyme- 
treated red cells [ 1,2] or to anti-D bound to papain- 
treated red cell stroma [3]. Since Clq must bind 
through 2 of its 6 heads to 2 separate IgM molecules 
on the cell surface [4-61, it has been suggested that 
anti-D molecules are too far apart on the red cell 
surface to allow Cl q to bind by two binding sites 
[7]. An alternative explanation is that Cl is able to 
bind to IgG anti-D on the cell surface but that there 
is failure in the subsequent activating steps. To differ- 
entiate between these 2 possibilities, the ability of 
1251-labelled Cl q to bind anti-D coated red cells was 
investigated. 
2. Materials and methods 
A potent IgG anti-D preparation was further 
purified as in [8] followed by Sephadex G-200 column 
chromatography to remove aggregates. An aliquot 
was labelled with 13’ I [9]. The concentration of the 
anti-D in the final preparation was 860 pg/ml. Cl q 
was prepared and labelled with lz51 as in [lo]. The 
specific activities of the anti-D and Cl q were based 
on the use of absorbance values at 280 nm of 14 and 
6.8 for 1 g/100 ml, respectively. 
The red cells had the probable genotype R ,Rz and 
w. The saline used throughout contained 0.17 M NaCl, 
0.003 M P04, bovine serum albumin 1 g/ 100 ml 
@H 7.0) ionic strength 16 mM HO at 20°C. Red cell 
numbers were estimated using a Coulter electronic 
counter. 
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2.1. A model of Clq binding to randomly distributed 
IgG molecules on the surface of red cells 
Cl q must bind to 2 molecules on the cell surface. 
If the maximum span of the Clq molecules is r, then 
the number of Cl q binding sites on the antibody- 
coated red cells will be given by the number of pairs 
of IgG molecules in which the 2 members of the pair 
lie within a distance r of each other. If the IgG anti-D 
molecules are randomly distributed on the red cell 
surface, then an expression giving the number of IgG 
molecules that lie as a pair within a distance r of each 
other can be derived from probability theory and is 
given by: 
N-Ade -da 12 
where N = the total number of IgG molecules on the 
surface of each cell; A is the surface area of the red 
cell (taken as 163 X IO-‘* m2; [ 1 l]);a = rw2 and d 
the density of the IgG/unit area of surface. 
3. Results 
3 .l . Binding of CIq to anti-D coated red cells 
In 4 separate experiments, red cells were heavily 
coated with unlabelled anti-D by adding an excess of 
antibody (-250-500 I.rg) for each I ml R ,R2 Rh-posi- 
tive cells, the latter having a total binding capacity of 
-60 ng anti-D/ml cells [ 121. After removing unbound 
anti-D by washing with saline, 1251-labelled Clq was 
added and both the number of binding sites for Cl q 
on the cells and the value of the functional equilibrium 
constant, K, was determined by Scatchard analysis 
as in [lo]. Rh-negative cells were similarly treated 
and used as controls. The uptake of 12’1-labelled Clq 
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Table 1 Table 2 
Number of binding sites for “‘I-labelled Clq on Rh positive The relationship between the numbers of anti-D molecules/ 
red cells heavily coated with non-radioactive anti-D and the cell and the number of Clq binding sites 
value of K for the reaction --___ 
Expt Cl q binding sites/ 
red cell 
Functional affinity 
constant K 
Anti-D bound to red cells 
(molecules/cell) 
Clq-binding sites 
cell 
1 1600 3.6 X 10’ M-i 
2 1150 2 x 1OB M-’ 
3 120 4.2 x 10’ M-’ 
4 650 3.9 X 10’ M-’ 
2.1 x lo4 630 
1.9 x lo4 570 
1.3 x lo4 450 
1.4 x lo4 420 
1.0 x lo4 120 
1.1 x lo4 120 
3.4 X 10’ (av.) 
by the Rh-negative cells was subtracted from the 
uptake on the Rh-positive cells. The estimate of the 
number of binding sites ranged from 650-1600 on 
each cell and the values of K varied from 2-4.2 X lO* 
M-’ (table 1). The variation in the number of binding 
sites resulted from the use of different anti-D to red 
cell ratios in each case. 
Calculations were made using values of r 4 10,20,30 
and 40 nm. The results of these calculations are 
shown in fig.1. 
4. Discussion 
3.2. Relationship between Clq-binding sites and 
density of anti-D on cells 
To determine whether the number of available 
Cl q-binding sites was a function of the amount of 
anti-D present on each cell, aliquots of cells were 
coated with varying amounts of 13’ I-labelled anti-D 
and the number of antibody molecules/cell deter- 
mined. The uptake of 125 I-labelled Cl q by these cells 
at equilibrium was then determined and the number 
of available Cl q-binding sites on the cells calculated 
using the law of mass action, since: 
These results demonstrate that Cl q can bind to 
anti-D-coated red cells provided that the density of 
anti-D on the surface is sufficiently great. Owing to 
the non-specific uptake of Clq onto cells, the sensi- 
tivity of the method used here was such that the 
minimum number of Cl q binding sites on each red 
15001 40 30 20 nm 
Clqbound x (1 +K x C1qfre.e) 
Total Clq binding sites = 
K ’ C1qfree 
The pre-determined average value of 3.4 X 1 O* M-r 
was used for K. Rh-negative cells were similarly treated 
to estimate non-specific uptake of radioactivity and 
these values subtracted from those obtained with the 
Rh-positive cells. The values obtained from this 
experiment as shown in table 2 and plotted in fig.1. 
anti-D molecules/cell x10-’ 
3.3. Theoretical calculation of expected number of 
Cl q-binding sites 
The expected number of Cl q-binding sites with 
varying densities of anti-D molecules was calculated 
using the equation derived from probability theory. 
Fig.1. The relationship between the number of Clqbinding 
sites on Rhpositive cells and the number of anti-D molecules 
on each cell. The continuous lines are theoretical values 
(calculated using probability theory) giving the expected 
numbers of pairs in which the two members of the pair lie 
within 10,20,30 and 40 nm of each other; (0) observed val- 
ues, using LasI-labelled Clq and “‘Habelled anti-D. 
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cell that could be detected with certainty was -100. 
Approximately this number were detected when the 
number of anti-D molecules on each cell was -10 000. 
At higher anti-D densities, the number of Cl q binding 
sites increased rapidly so that with a doubling of the 
density to 20 000 anti-D molecules/cell, there was a 
5-6-fold increase in Clq-binding sites. 
The theoretical number of expected binding sites 
was calculated making two assumptions: 
(i) That the anti-D is randomly distributed on the 
cell surface; 
(ii) That the Cl q must combine with 2 IgG mole- 
cules to form an adequately firm bond. 
The dimensions given for Clq in [ 131 indicate that 
the molecule could span -40 nm if fully stretched. A 
series of curves were therefore calculated to determine 
the number of pairs of IgG molecules that would lie 
within 10,20,30 and 40 nm of each other at various 
IgG densities. It can be seen from Iig.1 that the 
observed binding of Cl q fits the expected curve if 
the Cl q molecules were only able to bind to pairs of 
IgG molecules lying within 10 nm of each other. It is 
to be expected however that Cl q will not bind to all 
the available pairs of IgG molecules since it is likely 
that the combining regions on the Cl q heads and on 
the IgG must be correctly orientated towards each 
other for a firm bond to take place. The orientation 
of the combining area on the 6 heads of Cl q are 
probably fixed within narrow limits by their connec- 
tions to the collagenous ‘stalks’ [ 131 and thus it is 
probable that once one of the heads has bound to an 
IgG molecule, the other IgG molecule must be cor- 
rectly orientated to bind with a second head. The 
observed results are thus also compatible with the 
suggestion that Cl q can combine with IgG molecules 
as far apart as 30 or 40 nm but that only some of the 
pairs are correctly orientated to allow binding to two 
heads. 
The finding that Cl q can combine with anti-D on 
the red cell surface is consistent with the findings [3] 
that papain-treated red cell stroma coated with anti-D 
will consume complement components. It is known 
that proteolytic enzymes bring about aggregation of 
the D-antigen on stroma [ 141 and this presumably 
results in many anti-D molecules bound to the antigen 
approaching sufficiently close to allow sufficient 
binding of Cl to activate the complement cascade. 
The failure of anti-D to activate complement is 
thus not due to the inability to bind Clq but is 
probably due to a failure of activation of later stages. 
There may be a failure of Clr and Cls to activate 
even though Cl is bound (review [5]) or it may be 
due to inefficiency of C4 and C3 activation and depo- 
sition [ 151. 
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